X4 Pharmaceuticals: Q2 Earnings Snapshot
BOSTON (AP) _ X4 Pharmaceuticals, Inc. (XFOR) on Thursday reported a loss of $21.2 million in its second quarter.
The Boston-based company said it had a loss of 60 cents per share.
The results exceeded Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 65 cents per share.